How to Demonstrate the Clinical Impact of Off‐Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

Documenti analoghi

• Therapeutic Strategy for Patients With Heart Failure and Atrial Fibrillation
  di: Naoya Kataoka, et al.
  Pubblicazione: (2025)
• Optimal Indication of Superior Vena Cava Isolation in Patients With Recurrent Atrial Fibrillation
  di: Reo Sasajima, et al.
  Pubblicazione: (2025)
• How to Demonstrate the Underlying Mechanism of Sex Difference in the Incidence of Durable Pulmonary Vein Isolation
  di: Naoya Kataoka, et al.
  Pubblicazione: (2025)
• Tricuspid Regurgitation as a Marker or Therapeutic Target of Atrial Fibrillation Recurrence Following Pulmonary Vein Isolation
  di: Bunnshichi Miichi, et al.
  Pubblicazione: (2025)
• Successful Strategy to Perform Pulmonary Vein Isolation and Left Atrial Appendage Closure Concomitantly
  di: Naoya Kataoka, et al.
  Pubblicazione: (2025)